Clinical Trials Logo

Clinical Trial Summary

This project is designed to advance understanding of the incretin effect in health and disease. This system of gut-islet linkage is essential for normal glucose tolerance, impaired in T2DM, and amenable to therapeutic intervention. However, there are important gaps in understanding incretin function that limit application of this system; this project will address several of these. A secondary, but critical aspect of this research is focus on inter-individual variation in the physiology of the incretin system. This is a novel direction for research in this field and is critical to advancing the concept of individualized medical care in diabetes by establishing whether there is a physiologic basis for predicting the existence of responders and non-responders to incretin therapies. Currently, we have described only Aim 1 from this grant in this protocol registration. While Aim 2 and 3 are described in the grant, Aim 1 will be conducted first and the results from this Aim and / or the publication of other results in the field may affect the approach to Aims 2 and 3.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT02550548
Study type Interventional
Source Duke University
Contact
Status Completed
Phase Phase 1
Start date April 21, 2016
Completion date April 16, 2021

See also
  Status Clinical Trial Phase
Completed NCT04347252 - Glucagon Regulation of Glucose Metabolism Phase 1
Completed NCT05238987 - Effect of Taking a Single Tablet of Iron on Insulin Secretion N/A
Recruiting NCT01610154 - Contribution of Pancreatic αcells Function to Blood Glucose Regulation in Chinese Type 2 Diabetics― the Effect of Sitagliptin on Glucagon Secretion, Insulin Secretion and Insulin Resistance in Chinese Type 2 Diabetics N/A
Withdrawn NCT05794776 - Effect of Spinal Cord Stimulation (SCS) on Insulin Secretion in Humans N/A
Terminated NCT04314167 - Effect of Serum LDL Cholesterol Concentration on Pancreatic Insulin Secretion N/A
Completed NCT02844907 - Regulation of Insulin Secretion by the GLP-1 Receptor Phase 4
Completed NCT02870361 - Influence of Central Nervous Insulin Sensitivity on Insulin Secretion N/A
Completed NCT02668601 - Maternal GDM in Hispanic Youth: Risk for Obesity
Recruiting NCT04607096 - Intermittent Fasting to Improve Insulin Secretion N/A